New Members Join the Alliance
The CCRA is pleased to announce the addition of two new member organizations: Bladder Cancer Canada and Myeloma Canada, and we welcome new representatives: Michelle Colero, Executive Director, Bladder Cancer Canada and Martine Elias, Executive Director, Myeloma Canada.
Bladder Cancer Canada is the only national patient advocacy organization for the over 80,000 Canadians living with bladder cancer. In addition to its patient support mission, targeted research funding is an important organizational priority.
Myeloma Canada is the only national charitable patient organization created by, and for, Canadians impacted by myeloma. A patient-driven approach to research prioritization guides it research funding decision-making.
We look forward to learning about and from our newest members!

The CCRA congratulates Drs. Anne-Marie Mes-Masson and John Bell, two distinguished cancer researchers and past CCRA awardees, for their appointments as Officers of the Order of Canada in late December 2025.
Anne-Marie Mes-Masson, PhD, FCAHS, FRSC, Associate Scientific Director of ...
Effective January 1st, 2024, CCRA welcomes Dr. Rosilene Kraft as the incoming patient/family representative on the CCRA Advisory Board. Most recently, Rosilene served on the 2023 PIP Working Committee and was cross-appointed to the conference Scientific Program Committee. Sh...